Last updated: February 7th, 2025
Our Medical Affairs team will be attending MAPS Americas 2026, and we are looking forward to engaging with peers across the industry to exchange perspectives, explore evolving best practices, and discuss how Medical Affairs can continue to elevate its strategic impact.
Our Latest Project Insights
Establishing a Patient Advocacy Council to Guide Strategic Launch Planning
Optimizing Clinical Endpoints for Phase III Design
Elevating Investor Engagement in Early-Stage Therapeutic Development
Redefining the Treatment Paradigm in Mental Health
Pioneering Treatment Paradigm in Neurology
Strategic Repositioning of a GI Market Leader Amidst Evolving Market Dynamics
Our Expertise
Our Medical Affairs services specialize in developing impactful strategies and communications for medical affairs teams launching new therapies or moving into new disease states. Our unique value is being able to bring both scientific acumen and strategic horsepower to the table. Although science forms the core of the work that we do, what sets us apart is our strategic capability.
Our integrated team of scientist-strategists collaborate to provide a simple and refreshing approach to developing medical strategy, impactful and focused tactical plans, clear medical materials, and robust external publications.
Key Topics of Discussion at MAPS America 2026
AI in Medical Affairs: Practical Applications, Real Impact
Demonstrating the Value and Impact of Medical Affairs
Integrated Approach to Integrated Evidence Generation Planning
Replacing reactive, fragmented evidence efforts with a proactive, coordinated, and cross-functional approach involves aligning clinical, real-world, and stakeholder evidence needs while ensuring the right evidence is available at the right time to support critical decisions across the product lifecycle.
The Evolution of Field Medical Engagements
Redefining value in scientific engagement involves expanding Field Medical roles to reflect growing scientific, strategic, and cross-functional expectations. This evolution includes elevating stakeholder interactions through insight-driven, tailored scientific exchange and shifting performance measures away from activity-based metrics toward indicators of genuine scientific and clinical impact.
Our Service Offerings
Understanding the Science starts with a rigorous, evidence-based foundation. We integrate systematic literature reviews, disease state dossiers, scientific platforms, and a shared scientific lexicon to translate complex evidence into a clear, consistent understanding that supports alignment and strategic decision-making.
We develop Strategic Collaboration Models that define how advisors engage across working groups, advisory boards, and regional roundtables. Each model aligns the appropriate expertise, level of engagement, and advisor role to the intended outcome, ranging from defined strategic deliverables to insight generation and educational exchange, ensuring fit for purpose collaboration and clear value from every interaction.
A Medical Strategic Plan provides a data-driven framework to define an asset’s strategic priorities, objectives, and path to execution. We work closely with Medical teams to assess the current landscape, align on clear goals, and develop integrated strategic and tactical plans that support informed decision-making and effective execution.
We design and deliver Medical Education and Training solutions that equip Medical and Commercial teams with the knowledge, tools, and confidence needed to support effective engagement. Our approach focuses on clear, relevant, and practical training materials that translate strategy into consistent understanding and execution across audiences.
We support end-to-end publications and congress activities, including planning, attendance, and post-congress reporting, as well as the development of scientific abstracts and posters, oral presentations, manuscripts, and standard response letters. Our approach ensures aligned educational objectives, clear timelines, and consistent, high-quality scientific communication across congresses and publication channels.
We look forward to connecting with fellow Medical Affairs leaders to exchange perspectives on how teams are advancing strategy, strengthening cross-functional collaboration, and demonstrating the evolving value of Medical Affairs.
Meet with our Medical Affairs Experts?
If you are unable to meet on site, we are happy to follow up post-conference to share insights and continue the conversation.
Meet The Experts
Patrick Hillan
Partner
Patrick has more than a decade of experience in supporting Medical Affairs teams in the development of medical strategies as well as HCP engagement through the design, facilitation, and reporting of medical Advisory Boards and Strategic Working Groups. He has broad experience across different therapeutic areas, with a particular emphasis on psychiatry and neurology. Notably, he has provided support for pre-launch Medical Affairs activities related to therapies for Major Depressive Disorder, Postpartum Depression, Schizophrenia, Parkinson's disease, Angelman’s syndrome, and Alzheimer's disease. He holds a BSc (Hons) and MSc in Neuroscience from the University of Edinburgh.
Chris Zealey
Partner
Chris has close to a decade of experience in medical strategy and strategic communications, with expertise in developing strategic scientific narratives and communication resources, cross-functional and medical strategy, stakeholder engagement and insight generation. His focus is serving as a strategic and scientific partner to organizations launching new therapies or entering new disease areas. Recently, his work has focused on various rare disease indication launches and in-line therapy strategic planning.
Veronica Carson
Director
Veronica brings over 15 years of experience in medical strategy across cardiometabolic diseases, rare diseases, and vaccines, with expertise spanning clinical development, medical affairs, public affairs, marketing, and sales. She is skilled at translating scientific and strategic insights into clear, actionable direction that supports stronger patient outcomes.